Comcast and Team Gleason have partnered to drive inclusive innovation to improve the independence and quality of life for people with physical and speech disabilities, including those living with ALS, they report.
The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), Northwestern Medicine scientists discover, according to research published in Gene Therapy.
PathMaker Neurosystems Inc has received a $371K grant from the NIH to evaluate its motor neuron hyperexcitability suppression technology in ALS.
Researchers have identified an increased inflammatory signal in familial ALS patients compared to other ALS patients, pointing to immune characteristics that distinguish such patients and informing potential anti-inflammatory therapies.
Read More
Researchers have identified a new gene that may increase a person’s risk of developing ALS. The gene, called TP73, produces a protein to help regulate the life cycle of a cell.
Read More
Researchers at Boston Children’s Hospital, working in collaboration with Pfizer, report a high-throughput target and drug discovery platform using motor neurons made from ALS patients.
Read More
Coya Therapeutics Inc will host a key opinion leader (KOL) webinar on ALS001, the company’s lead asset for the treatment of amyotrophic lateral sclerosis (ALS), on Friday, June 11, 2021 at 11:30 am ET.
Read More
In partnership with the Pittsburgh Pirates, LiveLikeLou, and Phi Delta Theta, the Permobil Foundation gave a surprised fan a team-branded, custom Permobil power wheelchair at the Pirates home game on June 3.
Read More
Xtalks hosts the live webinar “ALS Biomarkers in Drug Development,” on Tuesday, June 22, 2021 at 11am EDT (4pm BST/UK).
Read More
The network connection between nerve cells in the spinal cord seems to play a critical role in the development of the severe disease ALS, researchers suggest, in a new study published in Nature Communications.
Read More
An international team of researchers led by scientists at the National Institutes of Health and the Uniformed Services University (USU) report they have discovered a new and unique form of amyotrophic lateral sclerosis (ALS) that affects children.
Read More
Via the NIH-funded BrainGate2 project, scientists have developed a brain-computer interface (BCI) designed to help people with spinal cord injuries and neurological disorders such as ALS to communicate.
Read More
In some cases of familial ALS, the origin lies in a gene called C9ORF72. But why do mutations in this gene kill motor neurons? The Genomic Instability Group may have found the answer, which they explain in The EMBO Journal.
Read More
The Muscular Dystrophy Association (MDA) announces programming and fundraising events in support of people living with Amyotrophic Lateral Sclerosis (ALS) throughout ALS Awareness Month in May.
Read More
A type of cell in the brain blood vessels could explain the origins and dynamics of amyotrophic lateral sclerosis (ALS), according to a study, the results of which suggest a hitherto unknown connection between the nervous and vascular systems.
Read More
The Muscular Dystrophy Association (MDA), in partnership with the International Association of Fire Fighters (IAFF), launches the 2021 “Fill the Boot” fundraising campaign.
Read More
Mitsubishi Tanabe Pharma America Inc (MTPA) announces findings from a new analysis evaluating the impact of symptom progression on the ability of people with amyotrophic lateral sclerosis (ALS) to independently conduct activities of daily living (ADLs).
Read More
Northwestern University scientists have identified the first compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to ALS (amyotrophic lateral sclerosis). Their study was published recently in Clinical and Translational Medicine.
Read More